Fulltext

Assessing the burden of pneumonia using administrative data from Malaysia, Indonesia, and the Philippines

Azmi S 1 , Aljunid SM 2 , Maimaiti N 3 , Ali AA 4 , Muhammad Nur A 4 , De Rosas-Valera M 5 Show all authors , Encluna J 6 , Mohamed R 7 , Wibowo B 8 , Komaryani K 9 , Roberts C 10

Affiliations 

  • 1 Azmi Burhani Consulting, Metropolitan Square, W103A, Jalan PJU 8/1, Damansara Perdana, 47820 Petaling Jaya, Selangor, Malaysia. Electronic address: [email protected]
  • 2 International Centre for Casemix and Clinical Coding, UKM Medical Centre, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia; Department of Health Policy and Management, Faculty of Public Health, Kuwait University, Kuwait City, Kuwait
  • 3 Department of Health Management, Faculty of Health Science, Necmettin Erbakan University, Konya, Turkey
  • 4 United Nations University - International Institute for Global Health, Kuala Lumpur, Malaysia
  • 5 Department of Health Philippines, Manila, Philippines
  • 6 Health Policy Development Program, Ministry of Health, Manila, Philippines
  • 7 Science University of Malaysia, Kubang Kerian, Kelantan, Malaysia
  • 8 National Centre for Casemix, Ministry of Health Indonesia, Jakarta, Indonesia
  • 9 Centre for Health Financing and Insurance, Ministry of Health Indonesia, Jakarta, Indonesia
  • 10 Pfizer Inc., Collegeville, Pennsylvania, USA
Int J Infect Dis, 2016 May 24;49:87-93.
PMID: 27235085 DOI: 10.1016/j.ijid.2016.05.021

Abstract

To describe the incidence, mortality, cost, and length of stay (LOS) of hospitalized community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) in three Southeast Asian countries: Malaysia, Indonesia, and the Philippines.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications